Business Description
RAMM Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA75150G1046
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.06 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.05 | |||||
Beneish M-Score | -1.66 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8 | |||||
3-Year EBITDA Growth Rate | 9 | |||||
3-Year EPS without NRI Growth Rate | 7.4 | |||||
3-Year FCF Growth Rate | 8.3 | |||||
3-Year Book Growth Rate | -11.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.1 | |||||
9-Day RSI | 51.11 | |||||
14-Day RSI | 60.08 | |||||
6-1 Month Momentum % | -40 | |||||
12-1 Month Momentum % | -72.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.77 | |||||
Quick Ratio | 2.57 | |||||
Cash Ratio | 1.6 | |||||
Days Inventory | 301.21 | |||||
Days Sales Outstanding | 57.12 | |||||
Days Payable | 83.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | 2.92 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.97 | |||||
Operating Margin % | -144.51 | |||||
Net Margin % | -177.97 | |||||
FCF Margin % | -96.42 | |||||
ROE % | -26.03 | |||||
ROA % | -23.9 | |||||
ROIC % | -25.76 | |||||
ROC (Joel Greenblatt) % | -37.17 | |||||
ROCE % | -25.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.67 | |||||
PB Ratio | 0.28 | |||||
Price-to-Tangible-Book | 0.26 | |||||
EV-to-EBIT | -0.44 | |||||
EV-to-EBITDA | -0.52 | |||||
EV-to-Revenue | 0.77 | |||||
EV-to-FCF | -0.93 | |||||
Price-to-Net-Current-Asset-Value | 1 | |||||
Price-to-Net-Cash | 6 | |||||
Earnings Yield (Greenblatt) % | -228.4 | |||||
FCF Yield % | -63.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RAMM Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 4.693 | ||
EPS (TTM) (C$) | -0.07 | ||
Beta | -1.74 | ||
Volatility % | 182.21 | ||
14-Day RSI | 60.08 | ||
14-Day ATR (C$) | 0.003412 | ||
20-Day SMA (C$) | 0.062 | ||
12-1 Month Momentum % | -72.73 | ||
52-Week Range (C$) | 0.015 - 0.12 | ||
Shares Outstanding (Mil) | 119.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RAMM Pharma Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RAMM Pharma Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
RAMM Pharma Corp Frequently Asked Questions
What is RAMM Pharma Corp(XCNQ:RAMM)'s stock price today?
When is next earnings date of RAMM Pharma Corp(XCNQ:RAMM)?
Does RAMM Pharma Corp(XCNQ:RAMM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |